Substantiation of manufacture technology development for the tablets of isosorbide dinitrate with modified release
DOI:
https://doi.org/10.14739/2409-2932.2019.2.170982Keywords:
modified release, tablets, dosage forms, isosorbide dinitrate, pellets, vasodilatorsAbstract
Isosorbide dinitrate belongs to the group of organic nitrates, the oldest representatives of antianginal drugs, and today is the first-choice drug for purchase and prevention of strokes. High prophylactic efficacy of prolonged forms of nitrates should be noted. The modified-release drugs based on isosorbide dinitrate can combine high pharmacological activity, a long period of therapeutic action, and the absence of serious side effects typical of all nitrate group drugs. The need for modern cardiological preparations with a high level of efficacy and safety creates the need for further development of drugs with modified release, especially for oral administration.
The purpose of the work is to choose the concept of a modern solid oral dosage form of isosorbide dinitrate and the technological approach for its implementation.
Materials and methods. Data analysis of domestic and foreign scientific literature.
Results. The analysis of the advantages and disadvantages of oral dosage forms with traditional immediate and modified release. Modified-release preparations are more technologically sophisticated, but provide a high level of safety, efficacy and convenience for the patient.
Conclusion. In the course of the study, the concept of a multidose pellet dosage form was selected to develop modified release isosorbide dinitrate tablets. To obtain pellets containing isosorbide dinitrate, the optimal technological solution is the method of extrusion-spheronization.
References
Kovalenko, V. M. (2009) Nastanova z kardiolohii [Instruction on cardiology]. Кyiv: Morion. [in Ukrainian].
Metelica, V. I. (2002) Spravochnik po klinicheskoj farmakologii serdechno-sosudistykh sredstv [Handbook of Clinical Pharmacology of Cardiovascular Agents]. Moscow: Binom; Saint Petrsburg. [in Russian].
Pavlov, S. V., Levchenko, K. V., & Gorbachova, S. V. (2017) Cardioprotective effects of the estrogen receptors modulators in the conditions of experimental acute myocardial infarction. Zaporozhye medical journal, 19(6), 731–736. doi: 10.14739/2310-1210.2017.6.114689
Ruban, E. A., Khokhlova, L. N., Bobrickaya, L. A., & Spiridonov, S. V. (2016) Sovremennye napravleniya v tehnologii tverdykh lekarstvennykh sredstv [Modern trends in the technology of solid drugs]. Kharkiv: NFaU. [in Russian]
Chen, X., Wen, H., & Park, K. (2010) Challenges and new technologies of oral controlled release. Oral controlled release formulation design and drug delivery: Theory to Practice, 16, 257–277. https://doi.org/10.1002/9780470640487.ch16
Maderuelo, C., Zarzuelo, A., & Lanao, J. M. (2011) Critical factors in the release of drugs from sustained release hydrophillic matrices. J. Control. Release, 154(1), 2–19. doi: 10.1016/j.jconrel.2011.04.002
Jantzen, G. M., & Robinson, J. R. (1995) Sustained and controlled-release drug delivery systems. Modern Pharmaceutics, 121(4), 501–502.
Wani, M. S. (2008) Controlled Release System. Pharmaceutical Reviews, 6(1), 41–46.
Nair, A. B., Vyas, H., & Kumar, A. (2010) Controlled release matrix uncoated tablets of enalapril maleate using HPMC alone. Journal of Basic and Clinical Pharmacy, 1(2), 71–75.
Rajput, G. C., Majmudar, F. D., Patel J. K., Thakor, R., & Rajgor, N. B. (2010) Stomach specific mucoadhesive microsphere as a controlled drug delivery system. International Journal on Pharmaceutical and Biological Research, 1(1), 30–41. doi: 10.4103/0975-8453.59515
Levina, M., & Rajabi-Siahboomi, A. R. (2004) The influence of excipients on drug release from Hydroxypropylmethylcellulose matrices. J. Pharm. Sci, 93(11), 2746–2754. doi: 10.1002/jps.20181
Aulton, M. E. (2008) The Design and Manufacture of Medicines. Philadelphia. Churchill Livingstone Elsevier.
Hayashi, T., Kanbe, H., Okada, M., Suzuki, M., Ikeda, Y., Onuki, Y., et al. (2005) Formulation, study and drug release mechanism of a new Theophylline sustained release preparation. Int. J Pharm, 304(1–2), 91–101. doi: 10.1016/j.ijpharm.2005.07.022
Bykov, V. A., Demina, N. B., Velikaya, E. V., Kemenova, V. A., & Chulyukov, O. G. (2005) Izuchenie vliyaniya razlichnykh faktorov na vysvobozhdenie lekarstvennykh veschestv iz matrichnykh tabletok [Influence of various pharmaceutical factors on drug release from matrix tablets]. Khimiko-farmacevticheskij zhurnal, 39(5), 40–45. [in Russian].
Kojima, H., Yoshihara, K., Sawada, T., Kondo, H., & Sako, K. (2008) Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets. Eur. J. Pharm. Biopharm, 70(2), 556–562. doi: 10.1016/j.ejpb.2008.05.032
Siahi, M. R., Jalali, M. B., Monajjemzadeh, F., Ghaffari, F., & Azarmi, S. (2005) Design and evaluation of 1- and 3-layer matrices of verapamil hydrochloride for sustaining its release. AAPS Pharm. Sci. Tech, 6(4), 626–632. doi: 10.1208/pt060477
Sudha, B. S., Sridhar, B. K., & Srinatha, A. (2010) Modulation of Tramadol Release from a Hydrophobic Matrix: Implications of Formulations and Processing Variables. AAPS Pharm. Sci. Tech, 11(1), 433–440. doi: 10.1208/s12249-010-9400-5
Kim, C. (2000) Controlled release dosage form design. Florida. USA: CRC Press.
Diakidoua, A., Vertzonia, M., Abrahamssonb, B., & Dressman, J., Reppas, C. (2009) Simulation of gastric lipolysis and prediction of felodipine release from a matrix tablet in the fed stomach. Eur. J. Pharm Sci, 37(2), 133–40. doi: 10.1016/j.ejps.2009.02.003
Nerurkar, J., Jun, H. W., Price, J. C., & Park, M. O. (2005) Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates. Eur. J. Pharm Biopharm, 61(1–2), 56–68. doi: 10.1016/j.ejpb.2005.03.003
Thawatchai, P. (2008) Variables Influencing Drug Release from Layered Matrix System Comprising Hydroxypropyl Methylcellulose. AAPS Pharm. Sci. Tech, 9(2), 668–674. doi: 10.1208/s12249-008-9085-1
Varshosaz, J., Tavakoli, N., & Kheirolahi, F. (2006) Use of Hydrophilic Natural Gums in Formulation of Sustained-release Matrix Tablets of Tramadol Hydrochloride. APPS Pharm. Sci. Tech, 7(1), 168–174. doi: 10.1208/pt070124
(2003) Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. Pharm. Sci. Tech, 4(3), 1–6. doi: 10.1208/pt040331
Maggi, L., Segale, L., Torre, M. L., Ochoa, M. E., & Conte, U. (2002) Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for controlled release of a water-soluble drug. Dimensionality study. Biomaterials, 23(4), 1113–1119. https://doi.org/10.1016/S0142-9612(01)00223-X
Conti, S., Maggi, L., Segale, L., Ochoa Machiste, E., Conte, U., Grenier, P., & Vergnault, G. (2007) Matrices containing NaCMC and HPMC 1. Dissolution performance characterization. Int. J. Pharm, 333(1–2), 136–142. doi: 10.1016/j.ijpharm.2006.11.059
Prajapati, G. B., & Patel, R. K. (2010) Design and in vitro evaluation of novel nicorandil sustained release matrix tablets based on combination of hydrophillic and hydrophobic matrix systems. International Journal of Pharmaceutical Sciences review and research, 1(1), 33–35.
Gross, R. M., & Kao, C. I. (2000) The Dow Chemical Company - A Leader in Advanced Materials Technology. Advanced materials., 12(23), 1717–1723.
Siepmann, J., & Peppas, N. A. (2001) Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48(2–3), 139–157. doi: 10.1016/S0169-409X(01)00112-0 •
Tiwari, S. B., & Rajabi-Siahboomi, A. R. (2008) Modulation of drug release from hydrophilic matrices. Pharmaceutical Technology, 20(9), 24–32.
Roy, P., & Shahiwala, A. (2009) Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Control Release, 134(2), 74–80. doi: 10.1016/j.jconrel.2008.11.011
Mohylyuk, V. (2014) Multipartikulyarnye tabletki [Multiparticular Pills]. Farmacevticheskaya otrasl', 2(43), 36–39. [in Russian].
Ghebre-Sellassie Pellets, I., & Ghebre-Sellassie, I. (1989) Pharmaceutical pelletization technology. New York.
Vervaet, C., Baert, L., & Remon, J. P. (1995) Extrusion–spheronisation a literature review. Int J Pharm, 116(2), 131–146. doi: 10.1016/0378-5173(94)00311-R
Lavanya, K. (2011) Pelletization technology: a quick review. Int J Pharm Sci Res., 2, 1337–1355.
Borisenko, A. (2008) Kompaktirovanie poroshkov – al'ternativa granulirovaniyu v psevdoozhizhennom sloe [Compaction of powders is an alternative to granulation in a fluidized bed]. Promyshlennoe obozrenie, 5, 58. [in Russian].
Kovacevic, J., Mladenovic, A., Djuris, J., & Ibric, S. (2016) Evaluation of powder, solution and suspension layering for the preparation of enteric coated pellets. Eur J Pharm Sci, 85, 84–93. doi: 10.1016/j.ejps.2016.01.018
Sahoo, G. P., & Parashar, B. (2013) Pharmaceutical processing – a review on spheronization technology. J Pharm Res Opin., 9, 65–68.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
